Genetic Factors Affecting the Severity of Beta Thalassemia
NCT00159042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2017-08-10
Summary
Patients with genetic diseases can have widely differing severities. We are looking for genetic factors which influence the severity of beta thalassemia.
Conditions
- Beta Thalassemia
Sponsors & Collaborators
-
Deborah Rund
lead OTHER
Principal Investigators
-
Ariella Oppenheim, PhD · Hadassah Medical Organization
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-07-31
- Primary Completion
- 2017-07-01
- Completion
- 2017-07-01
Countries
- Israel
Study Locations
More Related Trials
-
Long Term Beta Thalassemia Treatment: Findings From The Extension Period
NCT06490601 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Thrombophilia In Beta Thalassemia
NCT04219449 ·Status: NOT_YET_RECRUITING
-
Effects of Spirulina on Cardiac Functions in Children With Beta Thalassemia Major
NCT02597595 ·Status: COMPLETED ·Phase: NA
-
Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia
NCT06490627 ·Status: RECRUITING ·Phase: PHASE2
-
Genetic Variants Affecting the Clinical Severity of Beta Thalassemia
NCT04918056 ·Status: UNKNOWN
-
Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic Counter
NCT00481221 ·Status: UNKNOWN
-
Complications in Children With B- Thalassemia Major
NCT03462784 ·Status: UNKNOWN
-
Dermatological Abnormalities in Beta-thalassemia Major
NCT03894605 ·Status: UNKNOWN
-
The Change of Coagulation Markers in Children With β-thalassemia Disease After Stem Cell Transplantation
NCT00789516 ·Status: COMPLETED
-
B-Thalasaemia Trait and Its Possible Cardioprotective Role
NCT02428023 ·Status: UNKNOWN
-
Atrial Fibrillation in Beta-Thalassemia
NCT05508932 ·Status: RECRUITING
-
A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
NCT06271512 ·Status: RECRUITING
-
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study
NCT00661804 ·Status: COMPLETED
-
Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 Msec
NCT00879242 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Safety and Efficacy of the BD211 Drug Product in β-Thalassemia Major Participants
NCT05015920 ·Status: COMPLETED ·Phase: NA
-
Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia
NCT00809042 ·Status: COMPLETED ·Phase: PHASE2
-
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)
NCT00171301 ·Status: COMPLETED ·Phase: PHASE4
-
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 ·Status: COMPLETED
-
Screening for Alpha Thalassemia in Healthy Volunteers
NCT02692872 ·Status: ACTIVE_NOT_RECRUITING
-
The Role of OCTA in Patients Affected by Beta Thalassemia
NCT04582110 ·Status: COMPLETED
-
A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major
NCT06291961 ·Status: COMPLETED ·Phase: PHASE1
-
Thrombin Generation in Beta-thalassemia Major
NCT04962984 ·Status: UNKNOWN ·Phase: NA
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA
-
Hydroxyurea to Treat Beta-Thalassemia (Cooley's Anemia)
NCT00001958 ·Status: COMPLETED ·Phase: PHASE2
-
Genetic Profile of Alpha Thalassemia Children at Sohag University Hospital .
NCT06591936 ·Status: RECRUITING